APA

Rohde D., Schön C., Boerries M., Didrihsone I., Ritterhoff J., Kubatzky K. F., Völkers M., Herzog N., Mähler M., Tsoporis J. N., Parker T. G., Linke B., Giannitsis E., Gao E., Peppel K., Katus H. A. & Most P. (20150121). S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4. : EMBO molecular medicine.

Chicago

Rohde David, Schön Christoph, Boerries Melanie, Didrihsone Ieva, Ritterhoff Julia, Kubatzky Katharina F, Völkers Mirko, Herzog Nicole, Mähler Mona, Tsoporis James N, Parker Thomas G, Linke Björn, Giannitsis Evangelos, Gao Erhe, Peppel Karsten, Katus Hugo A and Most Patrick. 20150121. S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4. : EMBO molecular medicine.

Harvard

Rohde D., Schön C., Boerries M., Didrihsone I., Ritterhoff J., Kubatzky K. F., Völkers M., Herzog N., Mähler M., Tsoporis J. N., Parker T. G., Linke B., Giannitsis E., Gao E., Peppel K., Katus H. A. and Most P. (20150121). S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4. : EMBO molecular medicine.

MLA

Rohde David, Schön Christoph, Boerries Melanie, Didrihsone Ieva, Ritterhoff Julia, Kubatzky Katharina F, Völkers Mirko, Herzog Nicole, Mähler Mona, Tsoporis James N, Parker Thomas G, Linke Björn, Giannitsis Evangelos, Gao Erhe, Peppel Karsten, Katus Hugo A and Most Patrick. S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4. : EMBO molecular medicine. 20150121.